Bristol-Myers Squibb buy Guggenheim
Start price
08.04.26
/
50%
€49.69
Target price
08.04.27
€61.69
Performance (%)
13.91%
Price
11:45
€56.60
Summary
This prediction is currently active. The prediction currently has a performance of 13.91%. This prediction currently runs until 08.04.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 2.273% | 2.273% |
| iShares Core DAX® | 3,26 % | 2,07 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % |
| iShares S&P 500 | 2,80 % | 2,25 % |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (BMY) had its "buy" rating reaffirmed by Guggenheim. They now have a $72.00 price target on the stock.
Ratings data for BMY provided by MarketBeat